Fosun Pharma

Established in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; stock codes: 600196.SH, 02196.HK) is a leading healthcare group in the PRC. With the mission of persistently improving human health, Fosun Pharma’ s business covers all key sectors of healthcare industry chain including pharmaceutical manufacturing and R&D, healthcare services, medical diagnosis and devices, as well as pharmaceutical distribution and retail. Fosun Pharma maintains a national recognized enterprise technology center and a highly capable R&D team, with relentless efforts exerted on innovation and research of therapeutic areas including cardiovascular system, central nervous system, blood system, metabolism and alimentary system, anti-infection and oncology. Looking forward, Fosun Pharma will adhere to the brand philosophy of “Innovation for Good Health”, and will continue sticking to the development strategy of “organic growth, external expansion and integrated development” under the guidance of 4IN strategy (Innovation, Internationalization, Integration and Intelligentization) striving to become a top-tier enterprise in the global mainstream pharmaceutical and healthcare market.